NASDAQ:IMMX | Profit Breakdown | Immix Biopharma, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$12.46M-$11.54M-$11.56M
2026-03-31-$10.8M-$10.09M-$10.09M
2025-12-31-$10.89M-$10.68M-$10.69M
2025-09-30-$7.66M-$7.58M-$7.59M
2025-06-30-$6.72M-$6.61M-$6.62M
2025-03-31-$4.68M-$4.53M-$4.54M
2024-12-31-$4.99M-$4.8M-$4.81M
2024-09-30-$7.39M-$7.14M-$7.15M
2024-06-30-$4.7M-$4.4M-$4.39M
2024-03-31-$5.59M-$5.32M-$5.26M
2023-12-31-$5.38M-$5.15M-$5.09M
2023-09-30-$4.52M-$4.34M-$4.28M
2023-06-30-$3.72M-$3.59M-$3.58M
2023-03-31-$2.52M-$2.49M-$2.48M
2022-12-31-$3.79M-$3.79M-$3.8M
2022-09-30-$1.53M-$1.53M-$1.54M
2022-06-30-$1.56M-$1.56M-$1.56M
2022-03-31-$1.33M-$1.33M-$1.33M
2021-12-31-$598,338.00-$22.75M-$22.76M
2021-09-30-$347,991.00-$401,928.00-$403,265.00
2021-06-30-$243,165.00-$207,030.00-$208,638.00
2021-03-31-$162,520.00-$1.02M-$1.02M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$29.96M-$29.4M-$29.44M
2024-12-31-$22.67M-$21.66M-$21.61M
2023-12-31-$16.14M-$15.57M-$15.43M
2022-12-31-$8.22M-$8.22M-$8.23M
2021-12-31-$1.35M-$24.38M-$24.38M
2020-12-31-$453,852.00-$1.13M-$1.15M